Enzolytics Stock Price To Earning
| ENZC Stock | USD 0.0006 0.0001 14.29% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Enzolytics' long-term financial health and intrinsic value.
Enzolytics |
Enzolytics Company Price To Earning Analysis
Enzolytics' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Enzolytics has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The price to earning for all United States stocks is 100.0% higher than that of the company.
Enzolytics Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enzolytics' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Enzolytics could also be used in its relative valuation, which is a method of valuing Enzolytics by comparing valuation metrics of similar companies.Enzolytics is currently under evaluation in price to earning category among its peers.
Enzolytics Fundamentals
| Return On Asset | -7.05 | |||
| Operating Margin | (19.24) % | |||
| Current Valuation | 71.57 M | |||
| Shares Outstanding | 2.44 B | |||
| Price To Sales | 2,083 X | |||
| Revenue | 190 K | |||
| Gross Profit | 52.81 K | |||
| EBITDA | (886.77 K) | |||
| Net Income | (57.28 K) | |||
| Cash And Equivalents | 5.76 K | |||
| Total Debt | 233.12 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.63) X | |||
| Cash Flow From Operations | 4.89 M | |||
| Earnings Per Share | (4.76) X | |||
| Beta | -0.0481 | |||
| Market Capitalization | 125.65 M | |||
| Total Asset | 3.31 M | |||
| Net Asset | 3.31 M |
About Enzolytics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enzolytics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enzolytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enzolytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Enzolytics Pink Sheet
Enzolytics financial ratios help investors to determine whether Enzolytics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enzolytics with respect to the benefits of owning Enzolytics security.